314 related articles for article (PubMed ID: 17263589)
1. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Corona Gutierrez CM; Tinoco A; Navarro T; Contreras ML; Cortes RR; Calzado P; Reyes L; Posternak R; Morosoli G; Verde ML; Rosales R
Hum Gene Ther; 2004 May; 15(5):421-31. PubMed ID: 15144573
[TBL] [Abstract][Full Text] [Related]
3. Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine.
García-Hernández E; González-Sánchez JL; Andrade-Manzano A; Contreras ML; Padilla S; Guzmán CC; Jiménez R; Reyes L; Morosoli G; Verde ML; Rosales R
Cancer Gene Ther; 2006 Jun; 13(6):592-7. PubMed ID: 16456551
[TBL] [Abstract][Full Text] [Related]
4. Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.
Rosales R; López-Contreras M; Rosales C; Magallanes-Molina JR; Gonzalez-Vergara R; Arroyo-Cazarez JM; Ricardez-Arenas A; Del Follo-Valencia A; Padilla-Arriaga S; Guerrero MV; Pirez MA; Arellano-Fiore C; Villarreal F
Hum Gene Ther; 2014 Dec; 25(12):1035-49. PubMed ID: 25275724
[TBL] [Abstract][Full Text] [Related]
5. A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity.
Rosales C; Graham VV; Rosas GA; Merchant H; Rosales R
Cancer Immunol Immunother; 2000 Sep; 49(7):347-60. PubMed ID: 10999461
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
7. Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus.
Valdez Graham V; Sutter G; José MV; García-Carranca A; Erfle V; Moreno Mendoza N; Merchant H; Rosales R
Cancer; 2000 Apr; 88(7):1650-62. PubMed ID: 10738224
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccines.
Breitburd F; Coursaget P
Semin Cancer Biol; 1999 Dec; 9(6):431-44. PubMed ID: 10712890
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
Baldwin PJ; van der Burg SH; Boswell CM; Offringa R; Hickling JK; Dobson J; Roberts JS; Latimer JA; Moseley RP; Coleman N; Stanley MA; Sterling JC
Clin Cancer Res; 2003 Nov; 9(14):5205-13. PubMed ID: 14614000
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.
Vandepapeliere P; Barrasso R; Meijer CJ; Walboomers JM; Wettendorff M; Stanberry LR; Lacey CJ
J Infect Dis; 2005 Dec; 192(12):2099-107. PubMed ID: 16288373
[TBL] [Abstract][Full Text] [Related]
12. Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector.
Gao L; Chain B; Sinclair C; Crawford L; Zhou J; Morris J; Zhu X; Stauss H
J Gen Virol; 1994 Jan; 75 ( Pt 1)():157-64. PubMed ID: 7509369
[TBL] [Abstract][Full Text] [Related]
13. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.
Borysiewicz LK; Fiander A; Nimako M; Man S; Wilkinson GW; Westmoreland D; Evans AS; Adams M; Stacey SN; Boursnell ME; Rutherford E; Hickling JK; Inglis SC
Lancet; 1996 Jun; 347(9014):1523-7. PubMed ID: 8684105
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T
Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223
[TBL] [Abstract][Full Text] [Related]
15. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics.
Pomfret TC; Gagnon JM; Gilchrist AT
J Clin Pharm Ther; 2011 Feb; 36(1):1-9. PubMed ID: 21198715
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.
Kreijtz JH; Goeijenbier M; Moesker FM; van den Dries L; Goeijenbier S; De Gruyter HL; Lehmann MH; Mutsert Gd; van de Vijver DA; Volz A; Fouchier RA; van Gorp EC; Rimmelzwaan GF; Sutter G; Osterhaus AD
Lancet Infect Dis; 2014 Dec; 14(12):1196-207. PubMed ID: 25455987
[TBL] [Abstract][Full Text] [Related]
17. Anal condyloma acuminatum.
McCutcheon T
Gastroenterol Nurs; 2009; 32(5):342-9. PubMed ID: 19820442
[TBL] [Abstract][Full Text] [Related]
18. Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata.
Gammon DC; Reed KA; Patel M; Balaji KC
Am J Health Syst Pharm; 2008 Oct; 65(19):1830-3. PubMed ID: 18796424
[TBL] [Abstract][Full Text] [Related]
19. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia.
Barrasso R; De Brux J; Croissant O; Orth G
N Engl J Med; 1987 Oct; 317(15):916-23. PubMed ID: 3041217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
